Abstract
The field of epigenetic research has evolved dramatically in recent years and has given valuable insight into regulation and dysregulation of gene expression in health and disease. The knowledge of the mechanisms controlling epigenetic changes increased, and in more and more diseases, a role for epigenetics could be found. Rheumatoid arthritis is a chronic inflammatory, autoimmune disease that leads to joint destruction but also affects other tissues and organs. Its etiology is not yet clarified, but a combination of the genetic background and environmental factors is proposed to trigger the onset of the disease. Epigenetic changes might be the link between non-genetic risk factors and development of symptoms. Changes in DNA methylation and histone modifications have been detected in patients with RA and have been found to promote inflammation and joint destruction. Future studies will have to show which epigenetic changes are causative factors and which are induced at a later stage by the chronic inflammatory environment seen in the disease. This knowledge holds the potential for new preventive, predictive, and therapeutic opportunities in RA.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- ACPA:
-
anti-citrullinated peptide autoantibodies
- DNMT:
-
DNA methyltransferase
- EBV:
-
Epstein Barr virus
- H3:
-
histone 3
- H4:
-
histone 4
- HAT:
-
histone acetylases
- HDACs:
-
histone deacetylases
- HERV:
-
human endogenous retrovirus
- IGF:
-
Insulin-like growth factor
- IL:
-
interleukin
- MHC:
-
major histocompatibility complex
- PBMCs:
-
peripheral blood mononuclear cells
- RA:
-
rheumatoid arthritis
- SFN:
-
Sulforaphane
- SLE:
-
systemic lupus erythematodes
- TLRs:
-
Toll-like receptors
- Xi:
-
inactivated X chromosome
References
Bird A (2007) Perceptions of epigenetics. Nature 447(7143):396–398
West MA, Heagy W (2002) Endotoxin tolerance: a review. Crit Care Med 30(1 Suppl):S64–S73
Foster SL, Hargreaves DC, Medzhitov R (2007) Gene-specific control of inflammation by TLR-induced chromatin modifications. Nature 447(7147):972–978
Dominguez-Andres J, Fanucchi S, Joosten LAB, Mhlanga MM, Netea MG (2020) Advances in understanding molecular regulation of innate immune memory. Curr Opin Cell Biol 63:68–75
Avni O, Lee D, Macian F, Szabo SJ, Glimcher LH, Rao A (2002) T(H) cell differentiation is accompanied by dynamic changes in histone acetylation of cytokine genes. Nat Immunol 3(7):643–651
Baguet A, Bix M (2004) Chromatin landscape dynamics of the Il4-Il13 locus during T helper 1 and 2 development. Proc Natl Acad Sci U S A 101(31):11410–11415
Koyanagi M, Baguet A, Martens J, Margueron R, Jenuwein T, Bix M (2005) EZH2 and histone 3 trimethyl lysine 27 associated with Il4 and Il13 gene silencing in Th1 cells. J Biol Chem 280(36):31470–31477
Chang S, Aune TM (2007) Dynamic changes in histone-methylation ‘marks’ across the locus encoding interferon-gamma during the differentiation of T helper type 2 cells. Nat Immunol 8(7):723–731
Wang J, Lee S, Teh CE, Bunting K, Ma L, Shannon MF (2009) The transcription repressor, ZEB1, cooperates with CtBP2 and HDAC1 to suppress IL-2 gene activation in T cells. Int Immunol 21(3):227–235
Enya K, Hayashi H, Takii T, Ohoka N, Kanata S, Okamoto T et al (2008) The interaction with Sp1 and reduction in the activity of histone deacetylase 1 are critical for the constitutive gene expression of IL-1 alpha in human melanoma cells. J Leukoc Biol 83(1):190–199
Lu J, Sun H, Wang X, Liu C, Xu X, Li F et al (2005) Interleukin-12 p40 promoter activity is regulated by the reversible acetylation mediated by HDAC1 and p300. Cytokine 31(1):46–51
Schmeck B, Lorenz J, N’Guessan PD, Opitz B, van Laak V, Zahlten J et al (2008) Histone acetylation and flagellin are essential for legionella pneumophila-induced cytokine expression. J Immunol 181(2):940–947
Greco L, Romino R, Coto I, Di Cosmo N, Percopo S, Maglio M et al (2002) The first large population based twin study of coeliac disease. Gut 50(5):624–628
Nistico L, Fagnani C, Coto I, Percopo S, Cotichini R, Limongelli MG et al (2006) Concordance, disease progression, and heritability of coeliac disease in Italian twins. Gut 55(6):803–808
Aho K, Koskenvuo M, Tuominen J, Kaprio J (1986) Occurrence of rheumatoid arthritis in a nationwide series of twins. J Rheumatol 13(5):899–902
Silman AJ, MacGregor AJ, Thomson W, Holligan S, Carthy D, Farhan A et al (1993) Twin concordance rates for rheumatoid arthritis: results from a nationwide study. Br J Rheumatol 32(10):903–907
MacGregor AJ, Snieder H, Rigby AS, Koskenvuo M, Kaprio J, Aho K et al (2000) Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. Arthritis Rheum 43(1):30–37
Lefevre S, Knedla A, Tennie C, Kampmann A, Wunrau C, Dinser R et al (2009) Synovial fibroblasts spread rheumatoid arthritis to unaffected joints. Nat Med 15(12):1414–1420
Guillemin F, Briancon S, Klein JM, Sauleau E, Pourel J (1994) Low incidence of rheumatoid arthritis in France. Scand J Rheumatol 23(5):264–268
Doran MF, Pond GR, Crowson CS, O’Fallon WM, Gabriel SE (2002) Trends in incidence and mortality in rheumatoid arthritis in Rochester, Minnesota, over a forty-year period. Arthritis Rheum 46(3):625–631
Beighton P, Solomon L, Valkenburg HA (1975) Rheumatoid arthritis in a rural south African negro population. Ann Rheum Dis 34(2):136–141
Silman AJ, Ollier W, Holligan S, Birrell F, Adebajo A, Asuzu MC et al (1993) Absence of rheumatoid arthritis in a rural Nigerian population. J Rheumatol 20(4):618–622
Peschken CA, Esdaile JM (1999) Rheumatic diseases in North America’s indigenous peoples. Semin Arthritis Rheum 28(6):368–391
Jacobsson LT, Hanson RL, Knowler WC, Pillemer S, Pettitt DJ, McCance DR et al (1994) Decreasing incidence and prevalence of rheumatoid arthritis in Pima Indians over a twenty-five-year period. Arthritis Rheum 37(8):1158–1165
Kaipiainen-Seppanen O, Aho K, Nikkarinen M (2001) Regional differences in the incidence of rheumatoid arthritis in Finland in 1995. Ann Rheum Dis 60(2):128–132
Shichikawa K, Inoue K, Hirota S, Maeda A, Ota H, Kimura M et al (1999) Changes in the incidence and prevalence of rheumatoid arthritis in Kamitonda, Wakayama, Japan, 1965–1996. Ann Rheum Dis 58(12):751–756
Wiles N, Symmons DP, Harrison B, Barrett E, Barrett JH, Scott DG et al (1999) Estimating the incidence of rheumatoid arthritis: trying to hit a moving target? Arthritis Rheum 42(7):1339–1346
Barrett JH, Brennan P, Fiddler M, Silman A (2000) Breast-feeding and postpartum relapse in women with rheumatoid and inflammatory arthritis. Arthritis Rheum 43(5):1010–1015
Brennan P, Silman A (1994) Breast-feeding and the onset of rheumatoid arthritis. Arthritis Rheum 37(6):808–813
Jorgensen C, Picot MC, Bologna C, Sany J (1996) Oral contraception, parity, breast feeding, and severity of rheumatoid arthritis. Ann Rheum Dis 55(2):94–98
Karlson EW, Mandl LA, Hankinson SE, Grodstein F (2004) Do breast-feeding and other reproductive factors influence future risk of rheumatoid arthritis? Results from the nurses’ health study. Arthritis Rheum 50(11):3458–3467
Linos A, Worthington JW, O’Fallon WM, Kurland LT (1983) Case-control study of rheumatoid arthritis and prior use of oral contraceptives. Lancet 1(8337):1299–1300
Vandenbroucke JP, Witteman JC, Valkenburg HA, Boersma JW, Cats A, Festen JJ et al (1986) Noncontraceptive hormones and rheumatoid arthritis in perimenopausal and postmenopausal women. JAMA 255(10):1299–1303
Turner S, Cherry N (2000) Rheumatoid arthritis in workers exposed to silica in the pottery industry. Occup Environ Med 57(7):443–447
Olsson AR, Skogh T, Axelson O, Wingren G (2004) Occupations and exposures in the work environment as determinants for rheumatoid arthritis. Occup Environ Med 61(3):233–238
Mousavi-Jazi M, Bostrom L, Lovmark C, Linde A, Brytting M, Sundqvist VA (1998) Infrequent detection of cytomegalovirus and Epstein-Barr virus DNA in synovial membrane of patients with rheumatoid arthritis. J Rheumatol 25(4):623–628
Niedobitek G, Lisner R, Swoboda B, Rooney N, Fassbender HG, Kirchner T et al (2000) Lack of evidence for an involvement of Epstein-Barr virus infection of synovial membranes in the pathogenesis of rheumatoid arthritis. Arthritis Rheum 43(1):151–154
Newkirk MM, Watanabe Duffy KN, Leclerc J, Lambert N, Shiroky JB (1994) Detection of cytomegalovirus, Epstein-Barr virus and herpes virus-6 in patients with rheumatoid arthritis with or without Sjogren’s syndrome. Br J Rheumatol 33(4):317–322
Kouri T, Petersen J, Rhodes G, Aho K, Palosuo T, Heliovaara M et al (1990) Antibodies to synthetic peptides from Epstein-Barr nuclear antigen-1 in sera of patients with early rheumatoid arthritis and in preillness sera. J Rheumatol 17(11):1442–1449
Fox RI, Luppi M, Pisa P, Kang HI (1992) Potential role of Epstein-Barr virus in Sjogren’s syndrome and rheumatoid arthritis. J Rheumatol Suppl 32:18–24
Toussirot E, Roudier J (2007) Pathophysiological links between rheumatoid arthritis and the Epstein-Barr virus: an update. Joint Bone Spine 74(5):418–426
Carty SM, Snowden N, Silman AJ (2004) Should infection still be considered as the most likely triggering factor for rheumatoid arthritis? Ann Rheum Dis 63(Suppl 2):ii46–ii49
Pattison DJ, Harrison RA, Symmons DP (2004) The role of diet in susceptibility to rheumatoid arthritis: a systematic review. J Rheumatol 31(7):1310–1319
Pattison DJ, Winyard PG (2008) Dietary antioxidants in inflammatory arthritis: do they have any role in etiology or therapy? Nat Clin Pract Rheumatol 4(11):590–596
Cerhan JR, Saag KG, Merlino LA, Mikuls TR, Criswell LA (2003) Antioxidant micronutrients and risk of rheumatoid arthritis in a cohort of older women. Am J Epidemiol 157(4):345–354
Heliovaara M, Knekt P, Aho K, Aaran RK, Alfthan G, Aromaa A (1994) Serum antioxidants and risk of rheumatoid arthritis. Ann Rheum Dis 53(1):51–53
Comstock GW, Burke AE, Hoffman SC, Helzlsouer KJ, Bendich A, Masi AT et al (1997) Serum concentrations of alpha tocopherol, beta carotene, and retinol preceding the diagnosis of rheumatoid arthritis and systemic lupus erythematosus. Ann Rheum Dis 56(5):323–325
Knekt P, Heliovaara M, Aho K, Alfthan G, Marniemi J, Aromaa A (2000) Serum selenium, serum alpha-tocopherol, and the risk of rheumatoid arthritis. Epidemiology 11(4):402–405
Costenbader KH, Kang JH, Karlson EW (2010) Antioxidant intake and risks of rheumatoid arthritis and systemic lupus erythematosus in women. Am J Epidemiol 172:205–216
Vessey MP, Villard-Mackintosh L, Yeates D (1987) Oral contraceptives, cigarette smoking and other factors in relation to arthritis. Contraception 35(5):457–464
Hernandez Avila M, Liang MH, Willett WC, Stampfer MJ, Colditz GA, Rosner B et al (1990) Reproductive factors, smoking, and the risk for rheumatoid arthritis. Epidemiology 1(4):285–291
Criswell LA, Merlino LA, Cerhan JR, Mikuls TR, Mudano AS, Burma M et al (2002) Cigarette smoking and the risk of rheumatoid arthritis among postmenopausal women: results from the Iowa Women’s health study. Am J Med 112(6):465–471
Stolt P, Bengtsson C, Nordmark B, Lindblad S, Lundberg I, Klareskog L et al (2003) Quantification of the influence of cigarette smoking on rheumatoid arthritis: results from a population based case-control study, using incident cases. Ann Rheum Dis 62(9):835–841
Huizinga TW, Amos CI, van der Helm-van Mil AH, Chen W, van Gaalen FA, Jawaheer D et al (2005) Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins. Arthritis Rheum 52(11):3433–3438
Linn-Rasker SP, van der Helm-van Mil AH, van Gaalen FA, Kloppenburg M, de Vries RR, le Cessie S et al (2006) Smoking is a risk factor for anti-CCP antibodies only in rheumatoid arthritis patients who carry HLA-DRB1 shared epitope alleles. Ann Rheum Dis 65(3):366–371
Klareskog L, Stolt P, Lundberg K, Kallberg H, Bengtsson C, Grunewald J et al (2006) A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum 54(1):38–46
Liebold I, Grutzkau A, Gockeritz A, Gerl V, Lindquist R, Feist E et al (2021) Peripheral blood mononuclear cells are hypomethylated in active rheumatoid arthritis and methylation correlates with disease activity. Rheumatology (Oxford) 60(4):1984–1995
Schulz WA, Steinhoff C, Florl AR (2006) Methylation of endogenous human retroelements in health and disease. Curr Top Microbiol Immunol 310:211–250
Nagy G, Ward J, Mosser DD, Koncz A, Gergely P Jr, Stancato C et al (2006) Regulation of CD4 expression via recycling by HRES-1/RAB4 controls susceptibility to HIV infection. J Biol Chem 281(45):34574–34591
Hishikawa T, Ogasawara H, Kaneko H, Shirasawa T, Matsuura Y, Sekigawa I et al (1997) Detection of antibodies to a recombinant gag protein derived from human endogenous retrovirus clone 4-1 in autoimmune diseases. Viral Immunol 10(3):137–147
Piotrowski PC, Duriagin S, Jagodzinski PP (2005) Expression of human endogenous retrovirus clone 4-1 may correlate with blood plasma concentration of anti-U1 RNP and anti-Sm nuclear antibodies. Clin Rheumatol 24(6):620–624
Okada M, Ogasawara H, Kaneko H, Hishikawa T, Sekigawa I, Hashimoto H et al (2002) Role of DNA methylation in transcription of human endogenous retrovirus in the pathogenesis of systemic lupus erythematosus. J Rheumatol 29(8):1678–1682
Neidhart M, Rethage J, Kuchen S, Kunzler P, Crowl RM, Billingham ME et al (2000) Retrotransposable L1 elements expressed in rheumatoid arthritis synovial tissue: association with genomic DNA hypomethylation and influence on gene expression. Arthritis Rheum 43(12):2634–2647
Karouzakis E, Gay RE, Michel BA, Gay S, Neidhart M (2009) DNA hypomethylation in rheumatoid arthritis synovial fibroblasts. Arthritis Rheum 60(12):3613–3622
Martin-Trujillo A, van Rietschoten JG, Timmer TC, Rodriguez FM, Huizinga TW, Tak PP et al (2010) Loss of imprinting of IGF2 characterises high IGF2 mRNA-expressing type of fibroblast-like synoviocytes in rheumatoid arthritis. Ann Rheum Dis 69(6):1239–1242
Blunk I, Thomsen H, Reinsch N, Mayer M, Forsti A, Sundquist J et al (2020) Genomic imprinting analyses identify maternal effects as a cause of phenotypic variability in type 1 diabetes and rheumatoid arthritis. Sci Rep 10(1):11562
Zhou X, Chen W, Swartz MD, Lu Y, Yu R, Amos CI et al (2007) Joint linkage and imprinting analyses of GAW15 rheumatoid arthritis and gene expression data. BMC Proc 1(Suppl 1):S53
Nakano K, Whitaker JW, Boyle DL, Wang W, Firestein GS (2013) DNA methylome signature in rheumatoid arthritis. Ann Rheum Dis 72(1):110–117
Whitaker JW, Shoemaker R, Boyle DL, Hillman J, Anderson D, Wang W et al (2013) An imprinted rheumatoid arthritis methylome signature reflects pathogenic phenotype. Genome Med 5(4):40
Glossop JR, Emes RD, Nixon NB, Haworth KE, Packham JC, Dawes PT et al (2014) Genome-wide DNA methylation profiling in rheumatoid arthritis identifies disease-associated methylation changes that are distinct to individual T- and B-lymphocyte populations. Epigenetics 9(9):1228–1237
Ai R, Whitaker JW, Boyle DL, Tak PP, Gerlag DM, Wang W et al (2015) DNA Methylome signature in Synoviocytes from patients with early rheumatoid arthritis compared to Synoviocytes from patients with longstanding rheumatoid arthritis. Arthritis Rheumatol 67(7):1978–1980
Karouzakis E, Raza K, Kolling C, Buckley CD, Gay S, Filer A et al (2018) Analysis of early changes in DNA methylation in synovial fibroblasts of RA patients before diagnosis. Sci Rep 8(1):7370
Karouzakis E, Rengel Y, Jungel A, Kolling C, Gay RE, Michel BA et al (2011) DNA methylation regulates the expression of CXCL12 in rheumatoid arthritis synovial fibroblasts. Genes Immun 12(8):643–652
Takami N, Osawa K, Miura Y, Komai K, Taniguchi M, Shiraishi M et al (2006) Hypermethylated promoter region of DR3, the death receptor 3 gene, in rheumatoid arthritis synovial cells. Arthritis Rheum 54(3):779–787
Chen Y, Gorelik GJ, Strickland FM, Richardson BC (2010) Decreased ERK and JNK signaling contribute to gene overexpression in “senescent” CD4+CD28- T cells through epigenetic mechanisms. J Leukoc Biol 87(1):137–145
Nile CJ, Read RC, Akil M, Duff GW, Wilson AG (2008) Methylation status of a single CpG site in the IL6 promoter is related to IL6 messenger RNA levels and rheumatoid arthritis. Arthritis Rheum 58(9):2686–2693
Liu Y, Aryee MJ, Padyukov L, Fallin MD, Hesselberg E, Runarsson A et al (2013) Epigenome-wide association data implicate DNA methylation as an intermediary of genetic risk in rheumatoid arthritis. Nat Biotechnol 31(2):142–147
Wong AH, Gottesman II, Petronis A (2005) Phenotypic differences in genetically identical organisms: the epigenetic perspective. Hum Mol Genet 14 Spec No 1:R11–8. https://doi.org/10.1093/hmg/ddi116
Enzer I, Dunn G, Jacobsson L, Bennett PH, Knowler WC, Silman A (2002) An epidemiologic study of trends in prevalence of rheumatoid factor seropositivity in Pima Indians: evidence of a decline due to both secular and birth-cohort influences. Arthritis Rheum 46(7):1729–1734
Jacobsson LT, Jacobsson ME, Askling J, Knowler WC (2003) Perinatal characteristics and risk of rheumatoid arthritis. BMJ 326(7398):1068–1069
Simard JF, Costenbader KH, Hernan MA, Liang MH, Mittleman MA, Karlson EW (2010) Early life factors and adult-onset rheumatoid arthritis. J Rheumatol 37(1):32–37
Edwards CJ, Goswami R, Goswami P, Syddall H, Dennison EM, Arden NK et al (2006) Growth and infectious exposure during infancy and the risk of rheumatoid factor in adult life. Ann Rheum Dis 65(3):401–404
Mandl LA, Costenbader KH, Simard JF, Karlson EW (2009) Is birthweight associated with risk of rheumatoid arthritis? Data from a large cohort study. Ann Rheum Dis 68(4):514–518
Li S, Wong EM, Bui M, Nguyen TL, Joo JE, Stone J et al (2018) Causal effect of smoking on DNA methylation in peripheral blood: a twin and family study. Clin Epigenetics 10:18
Jaakkola JJ, Gissler M (2005) Maternal smoking in pregnancy as a determinant of rheumatoid arthritis and other inflammatory polyarthropathies during the first 7 years of life. Int J Epidemiol 34(3):664–671
Strahl BD, Allis CD (2000) The language of covalent histone modifications. Nature 403(6765):41–45
Hu N, Qiu X, Luo Y, Yuan J, Li Y, Lei W et al (2008) Abnormal histone modification patterns in lupus CD4+ T cells. J Rheumatol 35(5):804–810
Huber LC, Brock M, Hemmatazad H, Giger OT, Moritz F, Trenkmann M et al (2007) Histone deacetylase/acetylase activity in total synovial tissue derived from rheumatoid arthritis and osteoarthritis patients. Arthritis Rheum 56(4):1087–1093
Kawabata T, Nishida K, Takasugi K, Ogawa H, Sada K, Kadota Y et al (2010) Increased activity and expression of histone deacetylase 1 in relation to tumor necrosis factor-alpha in synovial tissue of rheumatoid arthritis. Arthritis Res Ther 12(4):R133
Gillespie J, Savic S, Wong C, Hempshall A, Inman M, Emery P et al (2012) Histone deacetylases are dysregulated in rheumatoid arthritis and a novel histone deacetylase 3-selective inhibitor reduces interleukin-6 production by peripheral blood mononuclear cells from rheumatoid arthritis patients. Arthritis Rheum 64(2):418–422
Meng Q, Pan B, Sheng P (2021) Histone deacetylase 1 is increased in rheumatoid arthritis synovium and promotes synovial cell hyperplasia and synovial inflammation in the collagen-induced arthritis mouse model via the microRNA-124-dependent MARCKS-JAK/STAT axis. Clin Exp Rheumatol 39:970–981
Klein K, Frank-Bertoncelj M, Karouzakis E, Gay RE, Kolling C, Ciurea A et al (2017) The epigenetic architecture at gene promoters determines cell type-specific LPS tolerance. J Autoimmun 83:122–133
Sohn C, Lee A, Qiao Y, Loupasakis K, Ivashkiv LB, Kalliolias GD (2015) Prolonged tumor necrosis factor alpha primes fibroblast-like synoviocytes in a gene-specific manner by altering chromatin. Arthritis Rheumatol 67(1):86–95
Angiolilli C, Grabiec AM, Ferguson BS, Ospelt C, Malvar Fernandez B, van Es IE et al (2016) Inflammatory cytokines epigenetically regulate rheumatoid arthritis fibroblast-like synoviocyte activation by suppressing HDAC5 expression. Ann Rheum Dis 75(2):430–438
Angiolilli C, Kabala PA, Grabiec AM, Van Baarsen IM, Ferguson BS, Garcia S et al (2017) Histone deacetylase 3 regulates the inflammatory gene expression programme of rheumatoid arthritis fibroblast-like synoviocytes. Ann Rheum Dis 76(1):277–285
Muller-Ladner U, Gay RE, Gay S (2002) Role of nuclear factor kappaB in synovial inflammation. Curr Rheumatol Rep 4(3):201–207
Saccani S, Pantano S, Natoli G (2001) Two waves of nuclear factor kappaB recruitment to target promoters. J Exp Med 193(12):1351–1359
Saccani S, Pantano S, Natoli G (2002) p38-dependent marking of inflammatory genes for increased NF-kappa B recruitment. Nat Immunol 3(1):69–75
Saccani S, Natoli G (2002) Dynamic changes in histone H3 Lys 9 methylation occurring at tightly regulated inducible inflammatory genes. Genes Dev 16(17):2219–2224
Dieker J, Muller S (2010) Epigenetic histone code and autoimmunity. Clin Rev Allergy Immunol 39(1):78–84
Plaue S, Muller S, van Regenmortel MH (1989) A branched, synthetic octapeptide of ubiquitinated histone H2A as target of autoantibodies. J Exp Med 169(5):1607–1617
Reumaux D, Meziere C, Colombel JF, Duthilleul P, Mueller S (1995) Distinct production of autoantibodies to nuclear components in ulcerative colitis and in Crohn’s disease. Clin Immunol Immunopathol 77(3):349–357
Kanai Y, Kawaminami Y, Miwa M, Matsushima T, Sugimura T (1977) Naturally-occurring antibodies to poly(ADP-ribose) in patients with systemic lupus erythematosus. Nature 265(5590):175–177
Sohn DH, Rhodes C, Onuma K, Zhao X, Sharpe O, Gazitt T et al (2015) Local joint inflammation and histone citrullination in a murine model of the transition from preclinical autoimmunity to inflammatory arthritis. Arthritis Rheumatol 67(11):2877–2887
Myzak MC, Tong P, Dashwood WM, Dashwood RH, Ho E (2007) Sulforaphane retards the growth of human PC-3 xenografts and inhibits HDAC activity in human subjects. Exp Biol Med (Maywood) 232(2):227–234
Dashwood RH, Ho E (2007) Dietary histone deacetylase inhibitors: from cells to mice to man. Semin Cancer Biol 17(5):363–369
Wutz A, Gribnau J (2007) X inactivation Xplained. Curr Opin Genet Dev 17(5):387–393
Carrel L, Willard HF (2005) X-inactivation profile reveals extensive variability in X-linked gene expression in females. Nature 434(7031):400–404
Lu Q, Wu A, Tesmer L, Ray D, Yousif N, Richardson B (2007) Demethylation of CD40LG on the inactive X in T cells from women with lupus. J Immunol 179(9):6352–6358
Ozbalkan Z, Bagislar S, Kiraz S, Akyerli CB, Ozer HT, Yavuz S et al (2005) Skewed X chromosome inactivation in blood cells of women with scleroderma. Arthritis Rheum 52(5):1564–1570
Chabchoub G, Uz E, Maalej A, Mustafa CA, Rebai A, Mnif M et al (2009) Analysis of skewed X-chromosome inactivation in females with rheumatoid arthritis and autoimmune thyroid diseases. Arthritis Res Ther 11(4):R106
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Ospelt, C., Gay, S. (2022). Epigenetic Epidemiology of Inflammation and Rheumatoid Arthritis. In: Michels, K.B. (eds) Epigenetic Epidemiology. Springer, Cham. https://doi.org/10.1007/978-3-030-94475-9_15
Download citation
DOI: https://doi.org/10.1007/978-3-030-94475-9_15
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-94474-2
Online ISBN: 978-3-030-94475-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)